The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration

EMBO Journal

Volumn 25, Issue 17, 2006, Pages 4084-4096

  Di Giovanni, Simone ^a,b   Knights, Chad D ^c   Rao, Mahadev ^c   Yakovlev, Alexander ^b   Beers, Jeannette ^b   Catania, Jason ^c   Avantaggiati, Maria Laura ^c   Faden, Alan I ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Axon regeneration; Coronin 1b; Neurite outgrowth; p53; Rab13

Indexed keywords

ACTIN BINDING PROTEIN; CORONIN 1B; GUANOSINE TRIPHOSPHATASE; LYSINE; PROTEIN P53; PROTEIN RAB13; RAB PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ACETYLATION; ANIMALS; AXONS; CELLS, CULTURED; CYTOSKELETON; LYSINE; MALE; MICE; MICROFILAMENT PROTEINS; NERVE REGENERATION; NEURITES; NEURONS; RAB GTP-BINDING PROTEINS; RATS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33748366999     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/sj.emboj.7601292     Document Type: Article

References (48)

1. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR (1995) High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 5: 931-936
2. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175-1184
3. Bareyre FM, Schwab ME (2003) Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci 26: 555-563
4. Bates S, Hickman ES, Vousden KH (1999) Reversal of p53-induced cell-cycle arrest. Mol Carcinogen 24: 7-14
5. Benowitz LI, Routtenberg A (1997) Gap-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20: 84-91
6. Bode AG, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805
7. Curtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E, Spinella MJ (2001) Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function. Oncogene 20: 2559-2569
8. Curtin JC, Spinella MJ (2005) P53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53. Oncogene 24: 1481-1490
9. de Hostos EL (1999) The coronin family of actin-associated proteins. Trends Cell Biol 9: 345-350
10. Di Giovanni S, De Biase A, Yakovlev A, Finn T, Beers J, Hoffman EP, Faden AI (2005a) In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J Biol Chem 280: 2084-2091
11. Di Giovanni S, Faden AI, Yakovlev A, Duke-Cohan JS, Finn T, Thouin M, Knoblach S, De Biase A, Bregman BS, Hoffman EP (2005b) Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth. FASEB J 19: 153-154
12. Di Giovanni S, Knoblach SM, Brandoli C, Aden SA, Hoffman EP, Faden AI (2003) Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol 53: 454-468
13. Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, Faden AI (2005c) Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci USA 102: 8333-8338
14. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS (2001) Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 24: 254-264
15. Emery DL, Royo NC, Fischer I, Saatman KE, McIntosh TK (2003) Plasticity following injury to the adult central nervous system: is recapitulation of a developmental state worth promoting? J Neurotrauma 20: 1271-1292
16. Glanzer JG, Haydon PG, Eberwine JH (2004) Expression profile analysis of neurodegenerative disease: advances in specificity and resolution. Neurochem Res 29: 1161-1168
17. Gottlieb E, Haffner R, King A, Asher G, Gruss P, Lonai P, Oren M (1997) Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J 16: 1381-1390
18. Harms K, Nozell S, Chen X (2004) The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci 61: 822-842
19. Kiryu-Seo S, Hirayama T, Kato R, Kiyama H (2005) Noxa is a critical mediator of p53-dependent motor neuron death after nerve injury in adult mouse. J Neurosci 25: 1442-1447
20. Hudson CD, Morris PJ, Latchman DS, Budhram-Mahadeo VS (2005) Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate. J Biol Chem 280: 11851-11858
21. Hudson CD, Podesta J, Henderson D, Latchman DS, Budhram-Mahadeo V (2004) Coexpression of Brn-3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis. J Neurosci Res 78: 803-814
22. Hughes AL, Gollapudi L, Sladek TL, Neet KE (2000) Mediation of nerve growth factor-driven cell cycle arrest in PC-12 cells by p53. Simultaneous differentiation and proliferation subsequent to p53 functional inactivation. J Biol Chem 275: 37829-37837
23. Hughes PE, Alexi T, Walton M, Williams CE, Dragunow M, Clark RG, Gluckman PD (1999) Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol 57: 421-450
24. Humphries CL, Balcer HI D'Agostino JL, Winsor B, Drubin DG, Barnes G, Andrews BJ, Goode BL (2002) Direct regulation of Arp2/3 complex activity and function by the actin binding protein coronin. J Cell Biol 159: 993-1004
25. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293
26. Kalb RK, Strittmatter SM (2000) Neurobiology of Spinal Cord Injury. New Jersey: Humana Press, pp 113-158
27. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Bacus SS, Stark GR, Gudkov AV (1997) Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 16: 1391-1400
28. Knights C, Catania J, Di Giovanni S, Muratoglu S, Perez R, Shwartzbeck A, Quong A, Zhang X, Beerman T, Pestell RG, Avantaggiati ML (2006) Distinct p53 acetylation cassettes differentially influence gene expression patterns and cell fate. J Cell Biol 173: 533-544
29. Kubo T, Yamashita T, Yamaguchi A, Hosokawa K, Tohyama M (2002) Analysis of genes induced in peripheral nerve after axotomy using cDNA microarrays. J Neurochem 82: 1129-1136
30. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823-827
31. Makwana M, Raivich G (2005) Molecular mechanisms in successful peripheral regeneration. FEBS J 272: 2628-2638
32. Miller FD, Pozniak CD, Walsh GS (2000) Neuronal life and death: an essential role for the p53 family. Cell Death Differ 7: 880-888
33. Montano X (1997) P53 associates with trk tyrosine kinase. Oncogene 15: 245-256
34. Ogawa H, Ishiguro HK, Gaubatz S, Livingston DM, Nakatani Y (2002) A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296: 1132-1136
35. Oku T, Itoh S, Okano M, Suzuki A, Suzuki K, Nakajin S, Tsuji T, Nauseef WM, Toyoshima S (2003) Two regions responsible for the actin binding of p57, a mammalian coronin family actin-binding protein. Biol Pharm Bull 26: 409-416
36. Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442
37. Poluha W, Schonhoff CM, Harrington KS, Lachyankar MB, Crosbie NE, Bulseco DA, Ross AH (1997) A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC-12 cells. J Biol Chem 272: 24002-24007
38. Pleasure SJ, Page C, Lee VH (1992) Pure, postmitotic, polarized human neurons derived from NTera2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12: 1802-1815
39. Raivich G, Bohatschek M, Da Costa C, Iwata O, Galiano M, Hristova M, Nateri AS, Makwana M, Riera-Sans L, Wolfer DP, Lipp HP, Aquzzi A, Wagner EF, Behrens A (2004) The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43: 57-67
40. Rogel A, Popliker M, Webb CG, Oren M (1985) P53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5: 2851-2855
41. Rybakin V, Clemen CS (2005) Coronin proteins as multifunctional regulators of the cytoskeleton and membrane trafficking. Bioessays 27: 625-632
42. Schmid P, Lorenz A, Hameister H, Montenarh M (1991) Expression of p53 during mouse embryogenesis. Development 113: 857-865
43. Schuler M, Green DR (2005) Transcription, apoptosis, p53: catch-22. Trends Genet 21: 182-187
44. Tang BL (2001) Protein trafficking mechanisms associated with neurite outgrowth and polarized sorting in neurons. J Neurochem 79: 923-930
45. Vousden KH, Prives C (2005) P53 and prognosis; new insights and further complexity. Cell 120: 7-11
46. Xu Y (2003) Regulation of p53 responses by post-translational modifications. Cell Death Differ 10: 400-403
47. Yakovlev AG, Di Giovanni S, Wang G, Liu W, Stoica B, Faden AI (2004) BOK and NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem 279: 28367-28374
48. Yakovlev AG, Faden AI (1995) Molecular biology of CNS injury. J Neurotrauma 12: 767-777